Dr. Huilin Shao is a Presidential Young Professor in the Department of Biomedical Engineering and a Principal Investigator of the Institute for Health Innovation & Technology (iHealthtech) at the National University of Singapore. Dr. Shao received her BA from Cornell University, with a double major in Biological Sciences and in Physics. She completed her dual PhD (Biophysics) at Harvard University and PhD (Medical Engineering and Medical Physics) from Harvard-MIT Health Sciences and Technology (HST).
Her research is focused on developing integrated nanotechnology-based platforms for molecular analyses of novel biomarkers. She has pioneered multiple platform technologies to advance molecular diagnostics. These novel technologies have the potential to not only transform clinical practice, but also empower true patient care. Her work has been published in top journals such as Nature Biotechnology, Nature Medicine, Nature Biomedical Engineering, Nature Communications and highlighted in major reviews and popular news media (e.g., BBC and CNA). In recognition of her achievement, Dr. Shao has received multiple awards, including James Mills Pierce Award, A*STAR Independent Fellowship, NUS Early Career Research Award, the L’Oreal For Women in Science National Fellowship, the 2019 Singapore Presidential Young Scientist Award and the 2020 Springer-Nature MINE Young Scientist Award.